Opinion
Video
Switching Treatments in Spinal Muscular Atrophy
Key opinion leaders share their strategies for discussing potential changes in therapy and transitioning between treatments with patients, emphasizing the importance of reassuring patients that such changes are intended to provide long-term benefits for managing their spinal muscular atrophy.
EP: 1.Clinical Features and Phenotypes of Spinal Muscular Atrophy
EP: 2.Natural History of Spinal Muscular Atrophy
EP: 3.Presentation of Adult Spinal Muscular Atrophy in Clinics
EP: 4.Transitions of Care: Moving Spinal Muscular Atrophy Patients from Pediatric/Adolescent Care to Adult Clinics
EP: 5.Key Players in Transitioning Patients with SMA from Pediatric Care to Adult Health Care
EP: 6.Managing Clinical Stability in Adults Spinal Muscular Atrophy Patients
EP: 7.Treatments Approved for Treatment of Spinal Muscular Atrophy
EP: 8.Factors Guiding Treatment Selection in Adult Spinal Muscular Atrophy
Now Viewing
EP: 9.Switching Treatments in Spinal Muscular Atrophy
EP: 10.Determining Treatment Success in Spinal Muscular Atrophy
EP: 11.Counseling Patients About Treatment Outcomes in Spinal Muscular Atrophy
EP: 12.Real-World Data and Stability with Nusinersen in Adult Patients with Spinal Muscular Atrophy
EP: 13.Real-World Data for Risdiplam in Adult Patients with Spinal Muscular Atrophy
EP: 14.Transition of Care in Young Adults With Spinal Muscular Atrophy
EP: 15.Recommendations for Clinicians Taking Care of Patients with SMA
- How would you approach a discussion about a change in therapy?
Related Videos
Related Content
